Curium Pharma data breach

Clerk's notes

Curium Pharma, a company specializing in radiopharmaceuticals and diagnostic imaging, filed a data security incident report with the New Hampshire Attorney General on June 24, 2025. This filing indicates that unauthorized access to their systems occurred, which may have compromised the personal information of certain individuals.

While the specific details of the unauthorized access type have not been disclosed, the report confirms that sensitive personal data entrusted to Curium Pharma could have been exposed. Given the nature of the company's operations, they typically handle various forms of your data for medical treatment and billing purposes.

The New Hampshire Attorney General's office is currently investigating the specifics of this incident. If you have received a formal data breach notification letter from Curium Pharma, it serves as their official communication that your information was potentially part of this exposure.

As an affected individual, it is crucial to carefully read the notification letter for specific information provided by Curium Pharma, including any offers for identity protection services. You should also remain vigilant by monitoring your personal accounts and statements for any unusual or suspicious activity.

Understanding the potential impact of a data breach can be challenging. If you have received a notification letter from Curium Pharma concerning this incident and wish to understand your options, you may be eligible for a no-cost review of your situation.

If a notification letter about this breach reached you, see every New Hampshire data breach on file or browse all cases.